FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380883903> ?p ?o ?g. }

• W4380883903 abstract "Abstract Background Based on the tau spreading hypothesis, anti‐tau antibodies have been developed that can bind to and eliminate the misfolded tau protein during the short extracellular period. However, trials with tau antibodies have come up short in improving clinical outcome in Progressive Supranuclear Palsy (PSP) or Alzheimer’s Disease (AD). It is unclear whether the negative outcomes were due to insufficient target engagement and to what extent the change of tau CSF biomarkers reflected the brain pharmacodynamics. Method A Quantitative Systems Pharmacology (QSP) computer platform of tau biology has been developed including tau species diversity and their respective concentration, neuronal activity‐dependent tau secretion, tau binding to membrane surface receptors HSPG and LRP1, tau‐antibody binding and subsequent internalization of tau at the synaptic cleft. This model is combined with a Physiology‐Based PharmacoKinetic (PBPK) model to derive brain target exposure of tau antibodies. In addition, a PBPK model is used to simulate the level of plasma and CSF biomarkers. Result The platform was calibrated with preclinical in‐vitro cellular assays and after injection of brain extract in Transgene mouse models and was further humanized using published data on seed‐competent tau from postmortem AD brain at different Braak stages. Combining the extracellular antibody exposure, the spatial dimensions and the dynamics of tau secretion, diffusion and binding to the membrane surface receptors, the model suggests that a very limited fraction (10‐20%) of misfolded tau protein can be captured by antibodies and cleared. Even less reduction (5‐10%) is predicted for Progressive Supranuclear Palsy due to the higher affinity of PSP‐4R tau for membrane surface receptors. The reductions in misfolded tau protein are greatest in earlier stages of the disease. With regard to epitope selection, we identify conditions where high specificity (i.e. monomeric vs misfolded tau) is superior to high sensitivity (affinity). Conclusion Advanced Quantitative Systems Pharmacology computer modeling combining drug exposure dynamics with mechanistic modeling allows to (1) generate testable hypotheses for the outcomes of current therapeutic interventions, (2) support improved clinical trial designs in terms of dosing, patient selection, background amyloid therapy and disease stage and (3) ultimately prioritize targets for addressing tau pathology." @default.
• W4380883903 created "2023-06-17" @default.
• W4380883903 creator A5033147916 @default.
• W4380883903 creator A5056294661 @default.
• W4380883903 creator A5084933395 @default.
• W4380883903 creator A5087503813 @default.
• W4380883903 date "2023-06-01" @default.
• W4380883903 modified "2023-09-27" @default.
• W4380883903 title "Learning from anti‐tau antibody clinical trials using computer simulation of spatial tau propagation" @default.
• W4380883903 doi "https://doi.org/10.1002/alz.064602" @default.
• W4380883903 hasPublicationYear "2023" @default.
• W4380883903 type Work @default.
• W4380883903 citedByCount "0" @default.
• W4380883903 crossrefType "journal-article" @default.
• W4380883903 hasAuthorship W4380883903A5033147916 @default.
• W4380883903 hasAuthorship W4380883903A5056294661 @default.
• W4380883903 hasAuthorship W4380883903A5084933395 @default.
• W4380883903 hasAuthorship W4380883903A5087503813 @default.
• W4380883903 hasBestOaLocation W43808839031 @default.
• W4380883903 hasConcept C102230213 @default.
• W4380883903 hasConcept C104317684 @default.
• W4380883903 hasConcept C139770010 @default.
• W4380883903 hasConcept C141035611 @default.
• W4380883903 hasConcept C142724271 @default.
• W4380883903 hasConcept C159654299 @default.
• W4380883903 hasConcept C169760540 @default.
• W4380883903 hasConcept C170493617 @default.
• W4380883903 hasConcept C185592680 @default.
• W4380883903 hasConcept C203014093 @default.
• W4380883903 hasConcept C2776477761 @default.
• W4380883903 hasConcept C2776925932 @default.
• W4380883903 hasConcept C2777739294 @default.
• W4380883903 hasConcept C2778670691 @default.
• W4380883903 hasConcept C2779134260 @default.
• W4380883903 hasConcept C28406088 @default.
• W4380883903 hasConcept C3017833866 @default.
• W4380883903 hasConcept C502032728 @default.
• W4380883903 hasConcept C55493867 @default.
• W4380883903 hasConcept C71924100 @default.
• W4380883903 hasConcept C86803240 @default.
• W4380883903 hasConcept C95444343 @default.
• W4380883903 hasConcept C98274493 @default.
• W4380883903 hasConceptScore W4380883903C102230213 @default.
• W4380883903 hasConceptScore W4380883903C104317684 @default.
• W4380883903 hasConceptScore W4380883903C139770010 @default.
• W4380883903 hasConceptScore W4380883903C141035611 @default.
• W4380883903 hasConceptScore W4380883903C142724271 @default.
• W4380883903 hasConceptScore W4380883903C159654299 @default.
• W4380883903 hasConceptScore W4380883903C169760540 @default.
• W4380883903 hasConceptScore W4380883903C170493617 @default.
• W4380883903 hasConceptScore W4380883903C185592680 @default.
• W4380883903 hasConceptScore W4380883903C203014093 @default.
• W4380883903 hasConceptScore W4380883903C2776477761 @default.
• W4380883903 hasConceptScore W4380883903C2776925932 @default.
• W4380883903 hasConceptScore W4380883903C2777739294 @default.
• W4380883903 hasConceptScore W4380883903C2778670691 @default.
• W4380883903 hasConceptScore W4380883903C2779134260 @default.
• W4380883903 hasConceptScore W4380883903C28406088 @default.
• W4380883903 hasConceptScore W4380883903C3017833866 @default.
• W4380883903 hasConceptScore W4380883903C502032728 @default.
• W4380883903 hasConceptScore W4380883903C55493867 @default.
• W4380883903 hasConceptScore W4380883903C71924100 @default.
• W4380883903 hasConceptScore W4380883903C86803240 @default.
• W4380883903 hasConceptScore W4380883903C95444343 @default.
• W4380883903 hasConceptScore W4380883903C98274493 @default.
• W4380883903 hasIssue "S7" @default.
• W4380883903 hasLocation W43808839031 @default.
• W4380883903 hasOpenAccess W4380883903 @default.
• W4380883903 hasPrimaryLocation W43808839031 @default.
• W4380883903 hasRelatedWork W1862556038 @default.
• W4380883903 hasRelatedWork W2766048906 @default.
• W4380883903 hasRelatedWork W2766057155 @default.
• W4380883903 hasRelatedWork W2803148012 @default.
• W4380883903 hasRelatedWork W2994914024 @default.
• W4380883903 hasRelatedWork W3115245153 @default.
• W4380883903 hasRelatedWork W3133688088 @default.
• W4380883903 hasRelatedWork W3134989973 @default.
• W4380883903 hasRelatedWork W3194901486 @default.
• W4380883903 hasRelatedWork W4220753642 @default.
• W4380883903 hasVolume "19" @default.
• W4380883903 isParatext "false" @default.
• W4380883903 isRetracted "false" @default.
• W4380883903 workType "article" @default.